Skip to content

Envoy Medical COCH Q4 2024 Annual earnings

Reported March 28, 2025 · Before market open

Revenue$42.0K
EPS-$0.45Miss by $0.12
EPS estimate-$0.33

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$100.0K
EPS estimate-$0.09

Financials

Q4 2024

Income statement

See full
Revenue$42.0K-55.8%
Gross profit-$115.0K+17.3%
Operating income-$4.5M+32.3%
Net income-$4.6M+5.7%
EPS (diluted)-$0.40-400%

Balance sheet

See full
Cash & equivalents$5.5M+30.0%
Total debt$945.0K+57.5%
Total equity-$18.8M-961%
Total assets$11.5M+39.5%

Cash flow

See full
Operating cash flow-$5.1M+54.3%
Free cash flow-$4.6M+59.2%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$28.95M-18.4%
Enterprise value$24.41M-23.4%
P/S128.7×+16.4×

Profitability

See full
Gross margin-229.8%+400pp
Operating margin-8,558.7%+7,686pp
Net margin-9,242.2%-216pp
FCF margin-8,412.9%+7,002pp

Returns & leverage

See full
Current ratio1.2×+0.2×

Versus estimates

Ask the moment Envoy Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Envoy Medical report Q4 2024 earnings?
Envoy Medical (COCH) reported Q4 2024 earnings on March 28, 2025 before market open.
What were Envoy Medical's Q4 2024 revenue and EPS?
Envoy Medical reported revenue of $42.0K and eps of $-0.45 for Q4 2024.
Did Envoy Medical beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.33 by $0.12.
Where can I find Envoy Medical's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001013762-25-004299) directly on SEC EDGAR. The filing index links above go to sec.gov.